Inappropriate Use of Budesonide Nebulizer in Intermittent Asthma

Introduction to Inappropriate Treatment

Nebulized corticosteroids are reserved for very specific populations, not for intermittent asthma with viral upper respiratory infections, according to the British Thoracic Society 1, 2, 3.
The British Thoracic Society guidelines state that nebulized corticosteroids lack published randomized controlled trials demonstrating effectiveness in adults with asthma and should only be prescribed after review by a respiratory specialist, primarily for steroid-dependent patients attempting to reduce oral corticosteroid doses 1, 2.

Nebulized bronchodilators (not corticosteroids) are indicated for acute severe asthma with features such as inability to complete sentences, respiratory rate ≥25/min, heart rate ≥110/min, or PEF ≤50% predicted 1, 4.

Intermittent asthma by definition does not require daily inhaled corticosteroid therapy, as stated by the Journal of Allergy and Clinical Immunology 5.

Nebulizers for chronic asthma should only be used at Step 4 or above of asthma management guidelines (severe persistent asthma with daily symptoms) 1, 3, 6.
Before prescribing nebulized therapy, formal evaluation with peak flow monitoring over 2-4 weeks is required to demonstrate at least 15% improvement from baseline 1, 3.

A short-acting beta-agonist (albuterol/salbutamol) via metered-dose inhaler for symptomatic relief of cough and any bronchospasm: 200-400 mcg (2-4 puffs) every 4-6 hours as needed, as recommended by the British Thoracic Society 1, 4, 7.
If symptoms suggest an asthma exacerbation (not just a simple cold), consider a short course of oral prednisolone 30-40 mg daily for 3-7 days 1, 6, 7.

If this patient has symptoms more than 2 days per week or nighttime awakenings more than twice per month, they would be reclassified as mild persistent asthma and should receive daily low-dose inhaled corticosteroid via standard inhaler (not nebulizer), according to the Journal of Allergy and Clinical Immunology 5.

Do not prescribe nebulizers without proper indication and assessment - this leads to inappropriate medicalization and unnecessary equipment costs, as stated by the British Thoracic Society 1, 3.
Do not confuse viral URI symptoms with asthma exacerbation requiring controller therapy - most patients with intermittent asthma and colds need only bronchodilators 4, 7.
Do not use nebulized corticosteroids as first-line therapy - they are reserved for complex cases under specialist supervision, according to the British Thoracic Society 1, 2, 8.